CASE STUDY - PHASE I/II ONCOLOGY

How a Global CRO Used AI to Compress 6 Months of Site Selection into 26 Days

A leading global CRO needed 13 qualified research sites for a complex first-in-human oncology protocol. Using AI-powered site selection and automated feasibility outreach, they received 43 sites in 26 days, more than triple their goal.

"We needed 13 sites. We had months of manual work ahead of us and a protocol that was anything but simple." 

CRO Study Team Lead

Get the Case Study

Results at a glance

SITES DELIVERED VS GOAL

330%
The CRO needed 13 qualified sites. They received 43, without compromising on quality or investigator fit.

DAYS TO COMPLETION

26
From initial kickoff to a finalized qualified

site list, all completed in under a month.

ENGAGEMENT RATE

89.5%
Nearly 9 in 10 targeted research sites responded to the outreach campaign, far exceeding industry norms.

NEW SITE CONTACTS

212
Verified PI, sub-PI, and coordinator contact information surfaced and validated across all targeted research sites.

ebook_cover_3d

What You'll Learn:

  • Checkmark How this CRO replaced months of manual outreach and spreadsheet tracking with AI
  • Checkmark The two-phase AI approach: Network Navigator for site identification + Feasibility Accelerator for automated engagement campaigns
  • Checkmark How automated multi-channel outreach drove an 89.5% site response rate
  • Checkmark Day-by-day breakdown: from protocol upload to 43 engaged sites in 26 days
  • Checkmark Downstream impact: reduced labor, negotiation leverage, and smarter future site selection
RELATED RESOURCES

More on AI in Clinical Trials

WEBINAR

From Protocol to Perfect Match: See AI-Powered Site Selection in Action

Watch how leading Sponsors, Biotechs and CROs use AI to identify, engage, and qualify the right research sites in minutes - not months. 

 

WATCH ON DEMAND
BLOG

How will CROs benefit from Generative AI?

READ NOW
PODCAST

From Olympian to AI Trailblazer: Simon Arkell’s Mission to Transform Healthcare

LISTEN
KEEP UP WITH RYGHT

Stay Connected

Subscribe to be the first to know about product updates, news and announcements.